Effects of rice bran oil on the blood lipids profiles and insulin resistance in type 2 diabetes patients

Journal of Clinical Biochemistry and Nutrition

Volumn 51, Issue 1, 2012, Pages 15-18

  Lai, Ming Hoang ^a   Chen, Yi Ting ^b   Chen, Ya Yen ^b   Chang, Jui Hung ^c   Cheng, Hsing Hsien ^b  

^a CARDINAL TIEN COLLEGE OF HEALTHCARE AND MANAGEMENT   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Blood lipids; Rice bran oil; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RICE BRAN OIL; SOYBEAN OIL; UNCLASSIFIED DRUG; VEGETABLE OIL;

ADULT; AGED; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; BLOOD EXAMINATION; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; RICE BRAN;

GLYCINE MAX;

EID: 84863487417     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-87     Document Type: Article

References (23)

1. Hanley AJ, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 2002; 25: 1177-1184. (Pubitemid 41071169)
2. Keys A. Serum cholesterol response to dietary cholesterol. Am J Clin Nutr 1986; 44: 309.
3. Franz MJ, Bantle JP, Beebe CA, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2002; 25: 148-198.
4. Sugano M, Tsuji E. Rice bran oil and cholesterol metabolism. J Nutr 1999; 127: 521S-524S.
5. Hunnicutt JW, Hardy RW, Williford J, McDonald JM. Saturated fatty acid-induced insulin resistance in rat adipocytes. Diabetes 1994; 43: 540-545. (Pubitemid 24096294)
6. Chen CW, Cheng HH. A rice bran oil diet increases LDL-receptor and HMG-CoA reductase mRNA expressions and insulin sensitivity in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Nutr 2006; 136: 1472-1476.
7. Rajnarayana K, Prabhakar MC, Krishna DR. Influence of rice bran oil on serum lipid peroxides and lipids in human subjects. Indian J Physiol Pharmacol 2001; 45: 442-444. (Pubitemid 33026897)
8. Kuriyan R, Gopinath N, Vaz M, Kurpad AV. Use of rice bran oil in patients with hyperlipidaemia. Natl Med J India 2005; 18: 292-296. (Pubitemid 43230596)
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
10. Lam YY, Hatzinikolas G, Weir JM, et al. Insulin-stimulated glucose uptake and pathways regulating energy metabolism in skeletal muscle cells: the effects of subcutaneous and visceral fat, and long-chain saturated, n-3 and n-6 polyunsaturated fatty acids. Biochem Biophys Acta 2011; 1811: 468-475.
11. Han MS, Lim YM, Quan W, et al. Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res 2011; 52: 1234-1246.
12. y mice with genetic type 2 diabetes. Lipids Health Dis 2011; 10: 120.
13. Chou TW, Ma CY, Cheng HH, Chen YY, Lai MH. A rice bran oil diet improves lipid abnormalities and suppress hyperinsulinemic responses in rats with streptozotocin/nicotinamide-induced type 2 diabetes. J Clin Biochem Nutr 2009; 45: 29-32.
14. Goldberg RB, Mellies MJ, Sacks FM, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation 1998; 98: 2513-2519. (Pubitemid 29001188)
15. Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in noninsulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316: 823-828. (Pubitemid 28112428)
16. Hobbs FD. Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control. Int J Cardiol 2006; 110: 137-145.
17. Streicher R, Kotzka J, Müller-Wieland D, et al. SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I. J Biol Chem 1996; 271: 7128-7133. (Pubitemid 26104151)
18. Kissebah AH. Low density lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1987; 3: 619-651. (Pubitemid 17112105)
19. Garvey WT, Kwon S, Zheng D, et al. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 2003; 52: 453-462. (Pubitemid 36173203)
20. Rivellese AA, Patti L, Kaufman D, et al. Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study. Atherosclerosis 2008; 200: 350-358.
21. Wilson TA, Nicolosi RJ, Woolfrey B, Kritchevsky D. Rice bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater extent than ferulic acid in hypercholesterolemic hamsters. J Nutr Biochem 2007; 18: 105-112. (Pubitemid 46048986)
22. Berger A, Rein D, Schäfer A, et al. Similar cholesterol-lowering properties of rice bran oil, with varied gamma-oryzanol, in mildly hypercholesterolemic men. Eur J Nutr 2005; 44: 163-173. (Pubitemid 40585515)
23. Madigan C, Ryan M, Owens D, Collins P, Tomkin GH. Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes Care 2000; 23: 1472-1477.